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Abstract
Background: Hemorrhagic transformation (HT) can be a devastating complication of ischemic stroke. Hyperbaric
oxygen preconditioning (HBO-PC) has been shown to improve blood-brain barrier (BBB) permeability in stroke
models. The purpose of this study is to examine whether HBO-PC attenuates HT after focal cerebral ischemia, and
to investigate whether the mechanism of HBO-PC against HT includes up-regulation of antioxidants in
hyperglycemic rats.
Methods: Male Sprague-Dawley rats (280-320 g) were divided into the following groups: sham, middle cerebral
artery occlusion (MCAO) for 2 h, and MCAO treated with HBO-PC. HBO-PC was conducted giving 100% oxygen at
2.5 atm absolute (ATA), for 1 h at every 24 h interval for 5 days. At 24 h after the last session of HBO-PC, rats
received an injection of 50% glucose (6 ml/kg intraperitoneally) and were subjected to MCAO 15 min later. At 24 h
after MCAO, neurological behavior tests, infarct volume, blood-brain barrier permeability, and hemoglobin content
were measured to evaluate the effect of HBO-PC. Western blot analysis of nuclear factor erythroid 2-related factor 2
(Nrf2) and heme oxygenase-1 (HO-1) was evaluated at multiple time-points before and after MCAO.
Results: HBO-PC improved neurological behavior test, and reduced infarction volume, HT and Evans blue
extravasation in the ipsilateral hemisphere at 24 h after MCAO. Western blot analysis failed to demonstrate up-
regulation of Nrf2 in HBO-PC group before and after MCAO. Paradoxically, HBO-PC decreased HO-1 expression at
24 h after MCAO, as compared with htMCAO group.
Conclusions: HBO-PC improved neurological deficits, infarction volume, BBB disruption, and HT after focal cerebral
ischemia. However, its mechanism against focal cerebral ischemia and HT may not include activation of Nrf2 and
subsequent HO-1 expression.
Keywords: Hemorrhagic transformation, MCAO, Hyperbaric oxygen preconditioning, Nuclear factor erythroid 2-
related factor 2 (Nrf2), Heme oxygenase-1 (HO-1)
Background
Hemorrhagic transformation (HT) of ischemic stroke
contributes largely to the early mortality and poor func-
tional recovery of affected patients. Experimental studies
have shown that preischemic hyperglycemia increases
the risk of bleeding into cerebral infarction area, which
aggravates brain damage after reperfusion [1]. Hypergly-
cemia-enhanced HT may be linked to increased activity
of inflammation and oxidative stress, which cause
blood-brain barrier (BBB) disruption and neuronal cell
death [2]. Oxidative stress leading to ischemic cell death
involves the formation of reactive oxygen species/reac-
tive nitrogen species (ROS/RNS), which induce BBB dis-
ruption through degradation of junctional proteins
composing tight junction [3,4].
Nuclear factor erythroid 2-related factor 2 (Nrf2), a
cap ‘n’ Collar transcription factor, regulates a lot of anti-
oxidant/detoxification genes acting in synergy to remove
ROS/RNS through sequential enzymatic reactions [5,6].
Under non-stressed conditions, Nrf2 interacts with
Kelch-like ECH-associated protein 1 (Keap l) to form
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gene expression. Upon activation, the Keap 1-Nrf2 com-
plex is dissociated, Nrf2 translocates into the nuclei to
bind antioxidant response element (ARE) and activates
ARE-dependent transcription of important antioxidant
and detoxification genes (Phase II genes) [5]. Phase II
genes, including heme oxygenase-1 (HO-1), glutathione
S-transferases (GSTs) and NAD(P)H quinone oxidore-
ductase, work in synergy to constitute a pleiotropic cel-
lular defense that scavenges ROS/RNS, detoxifies
electrophiles and xenobiotics, maintain intracellular
reducing potential [7,8]. HO-1 is a ubiquitous and
redox-sensitive inducible stress protein that degrades
heme to carbon monooxide, iron and biliverdin [9]. All
products of heme oxygenases exert strong antioxidant,
anti-inflammatory and antiapoptotic effects.
Hyperbaric oxygen preconditioning (HBO-PC) induces
tolerance against brain ischemia reperfusion injury by
up-regulation of antioxidant enzymes [10], as well as
ischemia tolerance in organs including the spinal cord
[11], myocardium [12], and liver [13]. Recent investiga-
tion indicated that HBO-PC could induce cytoprotective
effect on human microvascular endothelial cell via upre-
gulation of Nrf2 and HO-1 [14]. The purpose of this
study is to examine whether HBO-PC attenuates HT
after focal cerebral ischemia, and to investigate whether
the mechanism of HBO-PC against HT includes Nrf2/
HO-1 up-regulation in hyperglycemic rats.
Methods
Animal preparation and MCAO
All experiments were approved by the Institutional Ani-
mal Care and Use Committee of Loma Linda University;
96 male Sprague-Dawley rats were purchased from Har-
lan Laboratories (Indianapolis, IN) and randomly divided
into the following groups: middle cerebral artery occlu-
sion (MCAO) with hemorrhagic transformation
(htMCAO; n = 40), HBO preconditioned htMCAO
(HBO-PC; n = 40), and sham-operated group (sham; n
= 16) for analysis of Evans blue extravasation and Wes-
tern blot. All rats received 50% dextrose (6 ml/kg) intra-
peritoneally 30 min before MCAO to induce acute
hyperglycemia. Anesthesia was induced with ketamine
and xylazine (80 mg/kg and 10 mg/kg respectively,
intraperitoneally), followed by atropine at a dose of 0.1
mg/kg subcutaneously. During surgery and postoperative
period, rectal temperature was maintained at 37.0°C by
using a feedback-controlled heating pad.
MCAO was performed as reported previously [15].
Briefly, the right external carotid artery was isolated and
coagulated. A 4-0 nylon suture with a round tip was
inserted into the internal carotid artery through the
external carotid artery stump and advanced to occlude
t h eo r i g i n eo fM C A .T h es u t u r ew a sr e m o v e da t2h
after occlusion. Blood was obtained from the tail vein
for analysis of glucose level at multiple time-points.
HBO-PC regimen
Rats were pressurized in a research hyperbaric chamber
(1300B; Sechrist) at 2.5 atm absolutes with 100% oxygen
(flow of 22 L/min). Compression and decompression
were maintained at a rate of 5 psi/min. A 1-h HBO ses-
sion was administered daily for 5 consecutive days; the
last session was performed 24 h before MCAO.
2,3,5-triphenyltetrazolium chloride staining and
evaluation of infarction volume
As previously reported [15], 2,3,5-triphenyltetrazolium
chloride monohydrate (TTC) staining was performed to
determine the infarct volume at 24 h after MCAO. The
possible interference of brain edema with infarct volume
was corrected by standard methods (whole contralateral
hemisphere volume - nonischemic ipsilateral hemisphere
volume) and the infarct volume was expressed as a ratio
of infarct volume to the whole contralateral hemisphere
[16].
Spectrophotometric assay of hemoglobin
Hemorrhagic transformation was quantified with spec-
trophotometric assay of brain hemoglobin content [17].
At 24 h after MCAO (22 h after reperfusion) or sham-
operation, the animals were perfused transcardially with
0.1 mol/l phosphate-buffered saline under deep anesthe-
sia until the outflow fluid from the right atrium was col-
orless. The brain was rapidly removed and dissected into
the left hemisphere and the right hemisphere.
Cerebral hemorrhage was quantified using a previously
described spectrophotometric assay with some modifica-
tions [17]. A standard curve was obtained using a “vir-
tual” model of hemorrhage. Incremental volumes of
h o m o l o g o u sb l o o d( 0 ,2 ,4 ,8 ,1 6 ,3 2μl) were added to
the perfused brain tissue. The hemispheric brain tissue
was then homogenized in distilled water followed by 30-
min centrifugation (13,000 g). Drabkin reagent (1.6 ml;
Sigma) was added to 0.4 ml supernatant aliquots and
optical density was measured at 540 nm via spectro-
photometer (Spectronix 3000; Milton-Roy). Hemoglobin
measurements were performed and compared with the
standard curve to obtain data in terms of hemorrhage
volume. The total hemispheric hemoglobin content was
expressed as μl of blood per hemisphere.
Measurement of evans blue dye extravasation
The integrity of the BBB was investigated by measuring
the extravasation of Evans blue in sham, htMCAO, and
HBO-PC group (n = 5 each). Evans blue dye (2% in saline,
5 ml/kg) was injected intravenously at 23 h after operation.
One hour after Evans blue injection, the chest wall was
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with 0.1 mol/l phosphate-buffered saline through the left
ventricle to remove the intravascular localized dye until
colorless perfusion fluid was obtained from the right
atrium. After decapitation, brains were removed, weighed,
and homogenized in 1.0 ml of 0.1 mol/l phosphate-buf-
fered saline, and centrifuged at 15,000 rpm for 30 min.
Then 0.6 ml of the resultant supernatant was added to an
equal volume of trichloroacetic acid. After overnight incu-
bation at 4°C and centrifugation at 15,000 rpm for 30 min,
the supernatant was measured at 615 nm for absorbance
using a spectrophotometer (pectronix 3000; Milton-Roy).
The tissue content of Evans blue was quantified from a
linear standard curve and wase x p r e s s e da sm i c r o g r a m s
per gram of brain tissue [18].
Neurological scores
At 24 h after MCAO, a neurological examination was
performed by a blinded investigator as previously
described with modifications [19]. The scores given to
each rat at the completion of the evaluation was the
summation of all 7 individual test scores [20].
Western blot analysis
The animals were euthanized under general anesthesia
at 24 h after operation (n = 6, each group), 2 and 24 h
after the last HBO session (n = 5, each). Brains were
collected and protein extracts from nuclear and cytoso-
lic fraction were obtained using a nuclear extraction kit
and following the manufacturer protocol (Millipore).
Equal amounts of total protein (20 μg) were separated
in 10% SDS-PAGE and blotted onto nitrocellulose mem-
branes. The probing antibodies included polyclonal rab-
bit anti-Nrf2 antibody (1:1000; Abcam Inc), rabbit anti-
heme oxygenase 1 (HO-1) polyclonal antibody (1:1000;
Enzo Life Sciences), goat anti-actin (1:2000; Santa Cruz),
and mouse anti-histone H1 monoclonal antibody (1:500;
Millipore Inc). Bands were detected by ECL plus Wes-
tern blotting detection kit (GE Healthcare) and recorded
on X-ray film (Kodak). Bands were quantified by optical
density method using Image J software, and densities
were expressed relative to histone H1 (nuclear fraction),
actin (cytosolic fraction) or sham.
Statistical analyses
Data were expressed as the mean ± SEM. Statistical dif-
ferences among groups were analyzed by using one-way
analysis of variance follo w e db yt h eT u r k e ym e t h o d .
Comparisons between the two groups for the infarction
volume, hemorrhagic volume and the neurological
scores were assessed by the unpaired t-test, and for
m o r t a l i t yr a t eb yc h i - s q u a r et e s t .P < 0.05 was consid-
ered statistically significant.
Results
Blood glucose level
The glucose levels at 2 h after injection in both groups
were significantly higher than the baseline and high glu-
cose level was lasted by 6 h after injection. HBO-PC had
no effects on the blood glucose level (Figure 1).
HBO-PC attenuated the outcomes of hyperglycemia
induced HT at 24 h after MCAO
To examine whether HBO-PC exerts a beneficial effect
on HT after focal ischemia, neurological scores, infarc-
tion volume and hemorrhagic volume were evaluated in
htMCAO and HBO-PC group. HBO preconditioned ani-
mals showed statistically better neurological function as
compared with those of htMCAO group (7.00 ± 1.55
versus 12.58 ± 1.36, P < 0.01; Figure 2). HBO-PC signifi-
cantly reduced the infarction volume on TTC staining at
24 h after MCAO (0.260 ± 0.017 versus 0.126 ± 0.031, P
< 0.01; Figure 3A, B). Spectrophotometric measurement
of brain hemoglobin showed that hemoglobin contents
of HBO preconditioned animals were significantly lower
than those of htMCAO group (10.37 ± 1.69 versus
15.17 ± 0.76 μL/hemisphere, P < 0.05; Figure 3C).
Evans blue extravasation with righ hemisphere of
htMCAO animals was significantly increased as com-
pared with those of sham operated rats (4.52 ± 0.83 ver-
sus 1.99 ± 0.42 μg/g, P < 0.05). HBO-PC significantly
reduced the extravasation of Evans blue as compared
with those of htMCAO group (4.52 ± 0.83 versus 2.16 ±
0.47 μg/g, P < 0.05; Figure 4).
However HBO-PC failed to improve the mortality rate
as compared with htMCAO group (32.5% versus 37.5%
Figure 1 Hyperbarc preconditioning had no effect on blood
glcose levels at 4 time-points. Blood was obtained from the tail
vein for analysis of blood glcose before, 2 h, 4 h, and 6 h after
administration of dextrose. There were not significant differences in
the time course of blood glucose levels between HBO-PC group
and htMCAO group.
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died in the sham group.
HBO-PC failed to increase Nrf2 activity and HO-1
expression
Western blot analysis showed that HBO-PC had no
effect on Nrf2 regulation. No change was found in the
protein expression of Nrf2 in both fractions at 2 or 24
h after the last session of HBO, without subsequent
MCAO (Figure 5). Furthermore, there was no signifi-
cant difference in Nrf2 expression of both fractions at
24 h after MCAO as compared with htMCAO group
(Figure 6). Result also shows that no change was found
i nt i m e - c o u r s eo fH O - 1e x p r e s s i o n( F i g u r e5 C ) .H o w -
ever, It is notable that HBO-PC decreased HO-1 at 24
h after MCAO as compared with htMCAO group (Fig-
ure 6C).
Discussion
In this study, we investigated the effect of HBO-PC on
HT after transient MCAO and demonstrated that HBO-
PC reduced neurological deficit, infarction volume, BBB
permeability and HT at 24 h after ischemia. However,
no change was found in time-course of Nrf2 in nuclear
fraction and HO-1 in cytosolic fraction after repeated
HBO exposure, and Nrf2 in nuclear fraction was not
u p r e g u l a t e db yH B O - P Ca t2 4ha f t e rM C A O .
Paradoxically, HBO-PC reduced the protein expression
of HO-1 as compared to htMCAO group.
It has been previously suggested that exposure to non-
lethal stress can induce protection against subsequent
exposure to lethal or more severe stress of a different
kind, which is known as cross-tolerance [21]. HBO-PC
has been demonstrated to induce cross-tolerance against
global cerebral ischemia [22] and focal cerebral ischemia
[23]. Under the condition of critical oxidative stress like
reperfusion injury, effects of HBO-PC have been attribu-
ted not only to reducing ROS/RNS but also to increase
of antioxidants which are induced by non-lethal oxida-
tive stress.
Microarray analysis showed that gene expression of
Nrf2 and HO-1 was immediately upregulated after HBO
administration in human microvascular endothelial cells
[14]. In in vivo models, HBO has been shown to induce
HO-1 overexpression in the lung [24]. HBO-PC could
induce tolerance against ischemia-reperfusion injury by
upregulation of HO-1 expression and activity in liver
[25] and kidney [26]. Our data did not confirm these
findings in the brain of glucose enhanced HT model.
It has been demonstrated that repeated HBO reduced
superoxide dismutase and catalase while glutathione
peroxidase was up-regulat e da sc o m p a r e dt os i n g l e
exposure of HBO in blood plasma of patients [27] and
the liver of rats [28]. Hence, there is possibility that cer-
tain antioxidants may be reduced by repeated exposure
of HBO as compared with single exposure. Nrf2 is con-
sidered to be activated by ROS/RNS as a non-lethal
stress caused by HBO exposure. As a result, repeated
preconditioning with HBO down-regulates Nrf2 activa-
tion and its downstream effector HO-1 after ischmic
insult. On the other hand, several studies measured anti-
oxidants as potential indirect markers of oxidative stress
taking place in the brain with stroke [29]. Hemorrhagic
transformation and infarction volume of HBO precondi-
tioned group was significantly reduced in this current
study, which indicates HO-1 was up-regulated in pro-
portion to the degree of hemorrhagic transformation
and infarction. In any case, activated Nrf2/ARE pathway
and subsequent HO-1 up-regulation could not be
regarded as a cause of reducing HT after repeated HBO
exposure in focal ischemia rats.
In this study, hemoglobin leakage in the brain of
HBO-PC group was approximately 32% less than in
htMCAO group, whereas infarction volume was
approximately 52% less. These results indicate that
attenuation of HT after HBO-PC can be accountable for
reduction in infarction volume. However, Evans blue
extravasation in HBO-PC was significantly reduced and
approximating to those of the sham group at 24 h after
Figure 2 HBO preconditioning significantly improved
neurological outcome. Modified Garcia score was used. The
minimum neurological score (most severe) was 3, and the
maximum was 21. HBO preconditioning significantly improved the
postischemic neurological deficit at 24 h after MCAO.
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to reduce BBB permeability more effectively if observa-
tion is undertaken over an extended period. Previous
reports demonstrated that HBO-PC suppressed matrix
metalloproteinase (MMP) 9 activity after global ischemia
[30] and focal ischemia in brain [31]. In the context of
HT after cerebral ischemia, MMPs may degrade extra-
cellular matrix and vascular basal lamina, weaken ves-
sels, and predispose them to leakage and rupture. These
reports indicate that HBO-PC can reduce HT not only
due to the reduction of infarction volume but ameliora-
tion of BBB disruption.
H B O - P Cd i dn o tr e d u c et h em o r t a l i t yr a t ec o m a p r e d
to htMCAO group despite improvement in neurobeha-
vior tests and HT. It is possible that HBO-PC did not
improve systemic complications due to hyperglycemia
and MCAO that contributed to the high mortality
rates. Systemic complications such as extracellular
acidosis have been reported to occur after transient
MCAO in hyperglycemic rats [32]. Further study will
be needed to investigate the complications which are
not directly related to the brain damage but may cause
high mortality rates.
HBO-PC has been suggested to reduce oxidative
stress, inflammation, and apoptosis in ischemia-reperfu-
sion injury. The result of this study indicates that there
are some other mechanisms which contribute to attenu-
ate HT after glucose enhanced ischemia-reperfusion
injury in brain. To our knowledge, this is the first inves-
tigation that HBO-PC can reduce HT after ischemia.
Figure 3 HBO preconditioning significantly reduced infarction volume and hemorrhage volume.( A )R e p r e s e n t a t i v ew h o l eb r a i n sa n d
brain slices with 2,3,5-triphenyltetrazolium chloride staining of each groups were demonstrated. HBO-PC reduced infarction volume and
attenuated hemorrhagic transformation. (B) Bar graphs showing average infarct size calculated in six slices. HBO-PC significantly reduced infarct
volume at 24 h after reperfusion compared to htMCAO group. (C) Hemorrhage volume was significantly reduced with HBO-PC. *P > 0.05 vs.
htMCAO.
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1 h after injection, animals were sacrificed after cardiac perfusion and quantitative evaluation analysis was evaluated. Extravasated Evans blue
dye was significantly reduced by HBO-PC. *P > 0.05 vs. htMCAO,
#P > 0.05 vs. sham.
Figure 5 HBO preconditioning had no effect on Nrf2 and HO-1 regulation before tMCAO. Representative immunoblots of Nrf2 in nuclear
fraction (A), Nrf2 in cytosolic fraction (B), and HO-1 in cytosolic fraction (C) at different time points after the last session of hyperbaric oxygen
therapy. There was no statistically significant difference among each time points following HBO-PC.
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ism and to define the optimal regimen of HBO-PC.
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